The national cholesterol education program diet vs a diet lower in carbohydrates and higher in protein and monounsaturated fat: A randomized trial

Archives of Internal Medicine

Volumn 164, Issue 19, 2004, Pages 2141-2146

  Aude, Y Wady ^a   Agatston, Arthur S ^a   Lopez Jimenez, Francisco ^a   Lieberman, Eric H ^a   Almon, Marie ^a   Hansen, Melinda ^a   Rojas, Gerardo ^a   Lamas, Gervasio A ^a   Hennekens, Charles H ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b PH A   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; PROTEIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDUCATION PROGRAM; FAT INTAKE; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; WEIGHT REDUCTION;

ADULT; AGED; BODY MASS INDEX; CHOLESTEROL; DIET, FAT-RESTRICTED; DIET, REDUCING; DIETARY CARBOHYDRATES; DIETARY PROTEINS; FEMALE; HEALTH EDUCATION; HUMANS; LIPIDS; MALE; MIDDLE AGED; OBESITY; WAIST-HIP RATIO; WEIGHT LOSS;

EID: 6944229595     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.19.2141     Document Type: Article

References (56)

1. Ashley FW Jr, Kannel WB. Relation of weight change to changes in atherogenic traits: the Framingham Study. J Chronic Dis. 1974;27:103-114.
2. Kannel WB, D'Agostino RB, Cobb JL. Effect of weight on cardiovascular disease. Am J Clin Nutr. 1996;63(3 suppl):419S-422S.
3. Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change, and coronary heart disease in women: risk within the "normal" weight range. JAMA. 1995;273:461-465.
4. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999;341:1097-1105.
5. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998;338:1-7.
6. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677-685.
7. Lee IM, Manson JE, Hennekens CH, Paffenbarger RS Jr. Body weight and mortality: a 27-year follow-up of middle-aged men. JAMA. 1993;270:2823-2828.
8. Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among US adults: NHANES III (1988 to 1994). Obes Res. 1997;5:542-548.
9. National Institutes of Health, National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, Md: National Institutes of Health:1998.
10. Eckel RH, Krauss RM; AHA Nutrition Committee. American Heart Association Call to Action: obesity as a major risk factor for coronary artery disease. Circulation. 1998;97:2099-2100.
11. Wood PD, Stefanick ML, Dreon DM, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med. 1988;319:1173-1179.
12. Van Gaal LF, Wauters MA, De Leeuw IH. The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes Relat Metab Disord. 1997;21(suppl):S5-S9.
13. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord. 1992;16:397-415.
14. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: the Expert Panel. Arch Intern Med. 1988;148:36-69.
15. Grundy SM, Bilheimer D, Blackburn H, et al. Rationale of the diet-heart statement of the American Heart Association: report of nutrition committee. Circulation. 1982;65(suppl):839A-854A.
16. Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med. 1991;325:461-466.
17. Hunninghake DB, Stein EA, Dujovne CA, et al. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med. 1993;328:1213-1219.
18. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, et al. Efficacy of a National Cholesterol Education Program NCEP diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. Arterioscler Thromb Vasc Biol. 1995;15:1079-1085.
19. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb. 1992;12:911-919.
20. Mensink RP, Katan MB. Effect of monounsaturated fatty acids versus complex carbohydrates on high-density lipoproteins in healthy men and women. Lancet. 1987;1:122-125.
21. Katan MB, Grundy SM, Wiliet WC. Beyond low-fat diets. N Engl J Med. 1997;337:563-566.
22. Krauss RM, Eckel RH, Howard B, et al. AHA Dietary Guidelines: Revision 2000: a statement for healthcare professionals from the nutrition committee of the American Heart Association. Circulation. 2000;102:2284-2299.
23. Trudeau E, Dube L. Moderators and determinants of satisfaction with diet counseling for patients consuming a therapeutic diet. J Am Diet Assoc. 1995;95:34-39.
24. The Cleveland Clinic Foundation. Modification of Diet in Renal Disease (MDRD) Study: Dietary Satisfaction Questionnaire. Cleveland, Ohio: The Cleveland Clinic Foundation; 1989.
25. Williams SR. Inequality of Carbohydrates: The Glycemic Index: Nutrition and Diet Therapy. Boston, Mass: Times Mirror/Mosby College Publishing; 1989:60-61.
26. Lopez-Jimenez F, Heilbron R, Almon M, Korn H, Lamas GA, Agatston AS. The beneficial effect of a high-fat, high-protein, low-carbohydrate diet on body weight and HDL cholesterol. J Am Coll Cardiol. 1998;31(suppl):343A.
27. Warnick GR. Enzymatic methods for quantification of lipoproteins lipids: methods. Methods Enzymol. 1986;129:101-123.
28. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+precipitation procedure or quantification of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
29. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
30. Mattson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res. 1985;26:194-202.
31. Grundy SM. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med. 1986;314:745-748.
32. Spiller GA, Jenkins DA, Bosello O, Gates JE, Cragen LN, Bruce B. Nuts and plasma lipids: an almond-based diet lowers LDL-C while preserving HDL-C. J Am Coll Nutr. 1998;17:285-290.
33. Spiller GA, Jenkins DA, Cragen LN, et al. Effect of a diet high in monounsaturated fat from almonds on plasma cholesterol and lipoproteins. J Am Coll Nutr. 1992;11:126-130.
34. Frost G, Leeds AA, Dore CJ, Madeiras S, Brading S, Dornhorst A. Glycemic index as a determinant of serum HDL-cholesterol concentration. Lancet. 1999;353:1045-1048.
35. Frost G, Wilding J, Beecham J. Dietary advice based on the glycemic index improves dietary profile and metabolic control in type 2 diabetic patients. Diabet Med. 1994;11:397-401.
36. Jenkins DJ, Wolever TM, Kalmusky J, et al. Low-glycemic index diet in hyperlipidemia: use of traditional starchy foods. Am J Clin Nutr. 1987;46:66-71.
37. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280:1843-1848.
38. Daniels SR, Morrison JA, Sprecher DL, Khoury P, Kimball TR. Association of body fat distribution and cardiovascular risk factors in children and adolescents. Circulation. 1999;99:541-545.
39. Casassus P, Fontbonne A, Thibult N, et al. Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality: the Paris prospective study. Arterioscler Thromb. 1992;12:1387-1392.
40. Despres JP. Obesity and lipid metabolism: relevance of body fat distribution. Curr Opin Lipidol. 1991;2:5-15.
41. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10:497-511.
42. Grundy SM. Small LDL, atherogenic dyslipidemia, and metabolic syndrome. Circulation. 1997;95:1-4.
43. Lempiäinen P, Mykkänen L, Pyörälä K, Lakkso M, Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation. 1999;100:123-128.
44. Gaudet D, Vohl MC, Perron P, et al. Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene. Circulation. 1998;97:871-877.
45. Haffner SM. Impaired glucose tolerance, insulin resistance and cardiovascular disease. Diabet Med. 1997;14(suppl):S12-S18.
46. Eidelman R, Lamas GA, Hennekens CH. The new National Cholesterol Education Program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary heart disease. Arch Intern Med. 2002;162:2033-2036.
47. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen male study. Circulation. 1998;97:1029-1036.
48. Hokanson JE, Austin MA. Plasma triglyceride level as a risk factor for cardiovascular disease independent of high-density lipoprotein level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213-219.
49. Austin MA. Plasma triglyceride and coronary artery disease. Arterioscler Thromb. 1991:11:2-14.
50. Miller M, Seidler A, Moalemi A, Pearson TA. Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-term Study. J Am Coll Cardiol. 1998;31:1252-1257.
51. Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyles changes for reversal of coronary heart disease. JAMA. 1998;280:2001-2007.
52. Superko RH. Lipoprotein subclasses and atherosclerosis. Front Biosci. 2001;6:D355-D365.
53. McManus K, Antinoro L, Sacks F. A randomized controlled trial of a moderate-fat, low-energy diet compared with a low-fat, low-energy diet for weight loss in overweight adults. Int J Obes Relat Metab Disord. 2001;25:1503-1511.
54. National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity JAMA. 1996;276:1907-1915.
55. Kennedy E, Meyers L, Layden W. The 1995 dietary guidelines for Americans: an overview. J Am Diet Assoc. 1996;96:234-237.
56. Krauss RM, Deckelbaum RJ, Ernst N, et al. Dietary guidelines for healthy American adults: a statement for health professionals from the nutrition committee, American Heart Association. Circulation. 1996;94:1795-1800.